A Benchmark Side-by-Side Comparison of Two Well-Established Protocols for <i>in vitro</i> Hematopoietic Differentiation From Human Pluripotent Stem Cells.

Front Cell Dev Biol · 2021 · PMC8175661 · PMID 34095110

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a slight trendno p-value reported

Despite a slight trend in favor of protocol 1, no statistically significant differences were observed between protocols at any time point analyzed throughout EB development regarding the frequency of hemogenic endothelial (HE) precursors; CD43+ CD45−, CD45+, and CD45 + CD34 + hematopoietic derivatives; or the output of clonogenic progenitors.

also in 4,078 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.